Nestlé India, Tata Consumer and beauty brands target India’s emerging GLP-1 consumer market
Nestlé India and Dr. Reddy’s have launched Celevida GLP+, while Tata Consumer plans protein- and fibre-led food and beverage launches within 60 days. Sugar Cosmetics and Lakmé are also promoting plumping products as brands respond to GLP-1 users’ nutrition and appearance needs.
What happened
Indian beauty and nutrition brands are targeting GLP-1 users. Nestle India and Dr. Reddy’s JV launched Celevida GLP+, while Tata Consumer is developing protein-
Key facts
- 60 days
- a decade
- type 2 diabetes
Why this matters
Prioritize partnerships or acquisitions in clinical nutrition, high-protein food and beverage platforms, and science-backed beauty brands to establish an integrated GLP-1 consumer proposition.
What to watch
- Indian regulatory approvals, pricing changes or broader availability of GLP-1 and obesity-treatment drugs.
- Semaglutide patent-expiry developments and launches of lower-cost domestic alternatives.
- Repeat-purchase data for Celevida GLP+ and Tata Consumer's planned protein/fibre launches.
- Expansion of GLP-1-specific shelf sets in pharmacies, health stores, modern trade and quick-commerce apps.
- Clinical or regulatory guidance on nutrition management, muscle loss and micronutrient supplementation for GLP-1 users.
- Rising search, social and clinic conversation around 'Ozempic face,' hair loss, muscle preservation and protein intake in India.
- Competitive entries from dairy, sports nutrition, nutraceutical, meal-replacement and dermatology brands.
- Launch protein-and-fibre formats designed for Indian eating occasions, including shakes, snack bars, meal replacements, breakfast mixes and high-protein beverages.
- Build pharmacy-led distribution and doctor/dietitian education programs while avoiding unsupported drug-linked health claims.
- Use quick-commerce bundles combining protein, fibre, electrolyte and digestive-health products for weight-management consumers.
- Expand beauty messaging around hydration, barrier repair, plumping and post-weight-loss appearance, with cautious positioning that does not overclaim GLP-1 benefits.
- Pursue partnerships with telehealth, obesity clinics, diagnostic chains and wellness platforms to acquire recurring consumers.
- Develop lower-price sachets and regional flavors, since affordability will determine whether the category moves beyond affluent urban users.